Becton Dickinson & Co
- Market cap
- 49.07B
- P/E (TTM)i
- 54.43
- P/Bi
- 2.01
- EPSi
- 5.82
- Div yieldi
- 2.33%
- 52W posi
- 83%
Anonymous reader poll. Unscientific, not investment advice.
About Becton Dickinson & Co
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
- Founded
- 1897
- CEO
- Mr. Thomas E. Polen, Jr
- Employees
- 72,000
- Headquarters
- Franklin Lakes, New Jersey, United States of America
- Fiscal year end
- 09-30
- Website
- bd.com
Company profile
- Exchange
- US
- Symbol
- BDX
- Market-cap rank
- #450
- Listing date
- 1970-01-01
- Market cap
- 49.07B
- Float cap
- 48.94B
- Shares out
- 272.39M
- Float shares
- 271.67M
Sectors & themes
Quote time 2026-10-07 22:47:28 · For reference only, not investment advice and not tailored to your situation.